2024 Year in Review
As 2024 comes to a close, we reflect on a transformative year of discovery and growth at Gladstone. Advances in artificial intelligence, cellular reprogramming, and genetic editing are driving us closer to cures for diseases once thought untreatable.
Our scientists published nearly 160 peer-reviewed studies this year, with breakthroughs in Alzheimer’s, heart disease, cancer, and drug-resistant infections. Meanwhile, we embarked on an ambitious expansion of our Mission Bay campus, launching a $350 million campaign to add 15 new labs and hundreds of scientists. Revisit some of the most impactful moments that defined 2024.
Up Next
How AI Is Filling the Gaps in Women’s Health Research
A Gladstone-led study is collecting data from thousands of women wearing Oura Rings to make sense of what’s normal—and what could signal problems—when it comes to the menstrual cycle.
Christina Theodoris to Receive ASCI’s 2026 Seldin-Smith Award for Pioneering Research
The prestigious honor is presented by the American Society for Clinical Investigation to a physician-scientist making transformative contributions to biomedical research.
Gladstone’s Melanie Ott and Alex Marson Elected to the National Academy of Medicine
Physician-scientists and directors at Gladstone Institutes, Ott and Marson are honored for their pioneering achievements in science and medicine.
In Alzheimer’s Disease, the Brain’s Pacemaker Cells Lose Their Beat
Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain rhythms.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now